Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Watchlist Manager
Xinjiang Bai Hua Cun Pharma Tech Co Ltd Logo
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Watchlist
Price: 9.92 CNY -9.98%
Market Cap: 3.8B CNY

Operating Margin
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

11.3%
Current
4%
Average
5.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
44.6m
/
Revenue
393.7m

Operating Margin Across Competitors

No Stocks Found

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Metals & Mining

Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.

Xinjiang Bai Hua Cun Pharma Tech Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
44.6m
/
Revenue
393.7m
What is the Operating Margin of Xinjiang Bai Hua Cun Pharma Tech Co Ltd?

Based on Xinjiang Bai Hua Cun Pharma Tech Co Ltd's most recent financial statements, the company has Operating Margin of 11.3%.

Back to Top